Recent Quotes (30 days)

You have no recent quotes
chg | %

Concordia Healthcare Corp  

(Public, CVE:MV.H)   Watch this stock  
Find more results for MV.H
0.00 (0.00%)
Sep 19 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 1.00
Open     -
Vol / Avg. 0.00/0.00
Mkt cap 1.33M
P/E     -
Div/yield     -
EPS -1.44
Shares     -
Beta -1.15
Inst. own     -
May 15, 2015
Q1 2015 Concordia Healthcare Corp Earnings Call
May 14, 2015
Q1 2015 Concordia Healthcare Corp Earnings Release
Mar 20, 2015
Q4 2014 Concordia Healthcare Corp Earnings Call - Webcast
Mar 19, 2015
Q4 2014 Concordia Healthcare Corp Earnings Release

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 15.56% 9.49%
Operating margin 30.15% 28.51%
EBITD margin - 48.71%
Return on average assets 3.87% 3.04%
Return on average equity 8.76% 7.26%
Employees 214 -
CDP Score - -


277 Lakeshore Rd E Suite 302
+1-905-8425150 (Phone)
+1-905-8425154 (Fax)

Website links


Concordia Healthcare Corp. is a Canada-based diverse healthcare company. The Company is focused on legacy pharmaceutical products and orphan drugs. The Company operates through three segments, which includes Legacy Pharmaceutical Division, Concordia Pharmaceuticals Inc., which consists of 23 products, including Nilandron, for the treatment of metastatic prostate cancer; Dibenzyline, for the treatment of pheochromocytoma; Lanoxin, for the treatment of mild-to-moderate heart failure and atrial fibrillation; Plaquenil, for the treatment of lupus and rheumatoid arthritis; Donnatal, for the treatment of irritable bowel syndrome, and Zonegran (zonisamide), for treatment of partial seizures in adults with epilepsy. Its Specialty Healthcare Distribution (SHD) Division, Complete Medical Homecare, is engaged in the distribution of medical supplies focused on diabetes and related conditions. Its Orphan Drugs Division, Concordia Laboratories Inc., is engaged in the manufacture of PHOTOFRIN.

Officers and directors

Mark L. Thompson President, Chief Executive Officer, Founder, Director
Age: 46
Adrian de Saldanha Chief Financial Officer
Robert Altman Ph.D. President of Pinnacle
Age: 61
Wayne Kreppner Chief Operating Officer
Age: 41
Leith Tessy Treasurer, Secretary
Age: 52
John McCleery CPA Managing Director, Chief Financial Officer of CPI and CLI
Age: 56
Ronald D. Schmeichel J.D. Non-Executive Independent Chairman
Age: 47
Douglas N. Deeth Director
Age: 66
John-Michel T. Huss Independent Director
Age: 50
Jordan M. Kupinsky J.D. Independent Director
Age: 42